1. 2021
  2. In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection

    Sobesky, S., Mammadova, L., Cirillo, M., Drees, E. E. E., Mattlener, J., Dörr, H., Altmüller, J., Shi, Z., Bröckelmann, P. J., Weiss, J., Kreissl, S., Sasse, S., Ullrich, R. T., Reinke, S., Klapper, W., Gerhard-Hartmann, E., Rosenwald, A., Roemer, M. G. M., Nürnberg, P., Hagenbeek, A., & 6 othersZijlstra, J. M., Pegtel, D. M., Engert, A., Borchmann, P., von Tresckow, B. & Borchmann, S., 8 Oct 2021, In: Med (New York, N.Y.). 2, 10, p. 1171-1193.e11

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

    Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D. & Hagenbeek, A., 1 Apr 2021, In: Haematologica. 106, 4, p. 1129-1137 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

    FLASH group, 23 Mar 2021, In: Blood advances. 5, 6, p. 1737-1745 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2020
  6. Cancer-related fatigue in hodgkin lymphoma

    Kreissl, S., Hagenbeek, A., Knoop, H. & Borchmann, P., 2020, Hematologic Malignancies. Springer, p. 501-509 9 p. (Hematologic Malignancies).

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  7. Fair pricing of innovative medicines: An EHA position paper

    Hagenbeek, A., Gribben, J., Jäger, U., Kapitein, P., Merlini, G., Piggin, M., Uyl-de Groot, C. A. & Doeswijk, R., 2020, In: HemaSphere. 4, 5, A125.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. 2019
  9. Here to Stay: Biosimilars in Hematology

    Gribben, J., Merlini, G. & Hagenbeek, A., 1 Dec 2019, In: HemaSphere. 3, 6, e323.

    Research output: Contribution to journalEditorialAcademicpeer-review

  10. Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

    Hagenbeek, A., Mooij, H., Zijlstra, J., Lugtenburg, P., van Imhoff, G., Nijland, M., Tonino, S., Hutchings, M., Spiering, M., Liu, R., van Tinteren, H. & Kersten, M. J., Apr 2019, In: Haematologica. 104, 4, p. e151-e153

    Research output: Contribution to journalComment/Letter to the editorAcademic

  11. Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

    Morschhauser, F., Flinn, I. W., Advani, R., Sehn, L. H., Diefenbach, C., Kolibaba, K., Press, O. W., Salles, G., Tilly, H., Chen, A. I., Assouline, S., Cheson, B. D., Dreyling, M., Hagenbeek, A., Zinzani, P. L., Jones, S., Cheng, J., Lu, D., Penuel, E., Hirata, J., & 3 othersWenger, M., Chu, Y-W. & Sharman, J., 2019, In: Lancet. Haematology. 6, 5, p. e254-e265

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: A study by the Lunenburg Lymphoma Biomarker Consortium

    Rosenwald, A., Bens, S., Advani, R., Barrans, S., Copie-Bergman, C., Elsensohn, M-H., Natkunam, Y., Calaminici, M., Sander, B., Baia, M., Smith, A., Painter, D., Pham, L., Zhao, S., Ziepert, M., Jordanova, E. S., Molina, T. J., Kersten, M. J., Kimby, E., Klapper, W., & 16 othersRaemaekers, J., Schmitz, N., Jardin, F., Stevens, W. B. C., Hoster, E., Hagenbeek, A., Gribben, J. G., Siebert, R., Gascoyne, R. D., Scott, D. W., Gaulard, P., Salles, G., Burton, C., de Jong, D., Sehn, L. H. & Maucort-Boulch, D., 2019, In: Journal of clinical oncology. 37, 35, p. 3359-3368

    Research output: Contribution to journalArticleAcademicpeer-review

  13. 2017
  14. Affordability of medicines a top priority for EHA: Toward a fair pricing model for innovative medicines

    EHA Task Force on Fair Pricing, 2017, In: HemaSphere. 1, 1, e12.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 58473